Wilson Sonsini Goodrich & Rosati advised Aristea Therapeutics on the deal. Aristea announced the closing of a $63 million Series B financing led by Fidelity Management &...
Aristea’s $63 Million Series B Financing Round
Shell’s Acquisition of Inspire Energy Capital
Wilson Sonsini Goodrich & Rosati advised Inspire Energy Capital on the deal. Shell New Energies US LLC, a subsidiary of Royal Dutch Shell plc, announced that...
InSilico Medicine’s $255 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised InSilico Medicine on the deal. Ashurst represented Mirae Asset Capital. Hong Kong-based InSilico Medicine, a global leader in end-to-end artificial...
Gopuff’s Acquisition of RideOS
Wilson Sonsini Goodrich & Rosati advised rideOS on the deal. Gopuff, the go-to solution for immediate everyday needs, announced that it has entered into an agreement...
project44’s Acquisition of ClearMetal
Wilson Sonsini Goodrich & Rosati advised project44 on the deal. Project44 acquired San Francisco, California-based ClearMetal, a market leader in international supply chain visibility and predictive...
project44’s Acquisition of ClearMetal
Wilson Sonsini Goodrich & Rosati advised project44 on the deal. Project44 acquired San Francisco, California-based ClearMetal, a market leader in international supply chain visibility and predictive...
Snap Inc.’s $500 Million Acquisition of WaveOptics
Wilson Sonsini Goodrich & Rosati and RPC advised WaveOptics on the deal. Snap Inc. announced that it will acquire WaveOptics Ltd, a British augmented reality (AR)...